Stocks
Impax Laboratories, Inc.IPXL
YHDHealthcarePharmaceuticals$18.30+0.55%
Price as of · delayed, not real-time
Specializing in generic and specialty pharmaceuticals, this company focuses on developing and commercializing controlled-release and immediate-release formulations. Investors monitor its pipeline of generic drug approvals and its ability to compete in the complex generics market. The company's performance is closely tied to regulatory milestones and pricing pressures in the pharmaceutical industry.
Market Cap: $052W Range: $13.00-$25.70
Congressional Interest in Impax Laboratories, Inc. (IPXL)
2 members of Congress have disclosed 5 trades in Impax Laboratories, Inc. (IPXL), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
5
Unique Politicians
2
Buys
3
Sells
2
Who in Congress Is Trading IPXL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-31 | Josh Gottheimer | buy | $1K-$15K |
| 2012-03-10 | MICHAEL T. MCCAUL | sell | $15K-$50K |
| 2012-03-10 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2012-03-10 | MICHAEL T. MCCAUL | buy | $15K-$50K |
| 2012-03-10 | MICHAEL T. MCCAUL | sell | $15K-$50K |